Full Length Research Paper
References
Blanche S, Rouzioux C, Moscato ML, (1989). A prospective study of infants born to women seropositive for human immunodeficiency virus type 1. HIV Infection in Newborns French Collaborative Study Group. N. Engl. J. Med. 320:1643-1648. Crossref |
||||
Brenchley JM, Schacker TW, Ruff LE (2004). CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 200:749-59. Crossref |
||||
Cameron DW, Simonsen JN, D'Costa LJ (1989). Female to male transmission of human immunodeficiency virus type 1: risk factors for sero-conversion in men. Lancet 2:403-407. Crossref |
||||
CDC (1998). Management of possible sexual, injecting-drug-use, or other non-occupational exposure to HIV, including considerations related to antiretroviral therapy. M.M.W.R. 17:1-14. | ||||
CSA, ORCMacro (2001). Ethiopia Demographic and Health Survey. Addis Ababa and Calverston, MA (USA), Central Statistical Authority and ORCMacro. | ||||
Elder G, Sever J (1988). Neurologic disorders associated with AIDS retroviral infection. Review of Infectious Diseases 10 (2):286-302. Crossref |
||||
Eshete H, Heast N, Lindan K, Mandel J (l993). Ethnic conflicts, poverty, and AIDS in Ethiopia. Lancet 341:1219. Crossref |
||||
European Study Group (1992). Comparision of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. Br Med. J. 304:809-813. Crossref |
||||
Gebretensae GT (2003). HIV/AIDS in the Ethiopian military: perceptions, strategies, and impacts. Draft working paper for the CSIS Task Force on HIV/AIDS Committee on Destabilizing Impacts of HIV/AIDS. Addis Ababa. | ||||
Government of Ethiopia (1998). Policy on HIV/AIDS. Addis Ababa, GoE. | ||||
Government of Ethiopia (2004). A comprehensive strategic plan to combat HIV/AIDS epidemic in Ethiopia (2004-2007), Final Report. Addis Ababa: GoE. | ||||
Gwinn M, Wortley PM (1996). Epidemiology of HIV infection in women and newborns. Clin. Obstet Gynecol. 39:292-304. Crossref |
||||
Hessol NA, Lifson AR, Rutherford GW (1989). Natural history of human immunodefi-ciency virus infection and key predictors of HIV disease progression. AIDS Clin. Rev. 69-93. PMid:2488696 |
||||
Hladik W (2005). HIV/AIDS in Ethiopia: Where is the Epidemic Heading? Sexually Transmitted Infections 8:32-I35. | ||||
Kaplan EH, Heimer R (1992). A model-based estimate of HIV infectivity via needle sharing. J. Acquir. Immune. Defic. Syndr. 5:1116-118. PMid:1403641 |
||||
Kloos H (l993). Health impact of war. In H. Kloos and Z.A. Zein (eds), The Ecology of Health and Disease in Ethiopia 121-132. Boulder and Oxford: Westview Press. | ||||
Marmor M, Weiss LR, Lyden M (1986). Possible female-to-female transmission of human immunodeficiency virus. Ann. Intern. Med. 105:969. Crossref |
||||
MOH (2004). AIDS in Ethiopia. 5th edition. Addis Ababa: Ministry of Health. | ||||
Nair P, Alger L, Hines S (1993). Maternal and neonatal characteristics associated with HIV infection in infants of seropositive women. J. Acquir Immune Defic Syndr 6:298-302. PMid:8450405 |
||||
Nancy A, Hessol MSPH, Monica, Gandhi MD, Ruth M, Greenblatt, MD (2005). A Guide to the Clinical care of women with HIV. Health Resources and Services Administration, HIV/AIDS Bureau. | ||||
National Intelligence Council (2002). The next wave of HIV/AIDS: Nigeria, Ethiopia, Russia, India and China.Washington, D.C. | ||||
Nelson J (1988). Human immunodeficiency virus detected in bowel epithelium from patients with gastrointestinal symptoms. Lancet 8580:259-262. Crossref |
||||
Plummer FA, Simonsen JN, Cameron DW (1991) Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J. Infect. Dis. 163:233-239. Crossref |
||||
Pomerantz R (1987). Infection of the retina by human immunodeficiency virus type I. N.E.J.M. 317(26):1643-1647. Crossref |
||||
Quinn T C, Overbaugh J (2005). HIV/AIDS in women: an expanding epidemic. Science 308:1582-1583. Crossref |
||||
Quinn TC (1996). Global burden of the HIV pandemic. Lancet 348:99-106. Crossref |
||||
St. Louis ME, Kamenga M, Brown C (1993). Risk for perinatal HIV-1 transmission according to maternal immunologic, virologic, and placental factors. J.A.M.A. 269:2853-2859. Crossref |
||||
Tokars JI, Marcus R, Culver DH, (1993). For the CDC Cooperative Needlestick Surveillance Group. Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. Ann. Intern. Med. 118:913-919. Crossref |
||||
UNAIDS (2002). AIDS epidemic update: December 2002. Geneva, Switzerland, UNAIDS/WHO. | ||||
UNAIDS (2002). AIDS epidemic update: December 2002. Geneva, Switzerland, UNAIDS/WHO, 2002. | ||||
UNAIDS UNICEF and WHO (2004). Ethiopia, epidemiological fact sheets on HIV/AIDS and sexually transmitted infections. Geneva: WHO. | ||||
Updated US (2001). Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. MMWR Rep. 50:1-52. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0